SCHEDULE 13D

Company

FENNEC PHARMACEUTICALS INC.

Filed

May 18, 2017

Accession Number

0001013594-17-000398

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →